For the same reason, tumors induced by any of these pathways (Ink4a-Arf, p53 apoptotic pathway in lymphomas, or c-Myc tumor model where c-Myc is expressed upon activation of the μ enhancer) cannot originate from stem cells. Here, CDKN2A is linked to lymphoma.